BIOMAT Database Logo BIOMAT Database Logo

Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure. 1977

L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D006909 Hydroxyproline A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation. Oxyproline,4-Hydroxyproline,cis-4-Hydroxyproline,4 Hydroxyproline,cis 4 Hydroxyproline

Related Publications

L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
May 1976, Lancet (London, England),
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
July 1978, Israel journal of medical sciences,
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
1alpha-Hydroxycholecalciferol in renal osteodystrophy.
May 1977, Calcified tissue research,
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
Bone mineral content in chronic renal failure during long-term treatment with 1alpha-hydroxycholecalciferol.
January 1978, Acta medica Scandinavica,
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
August 1976, Calcified tissue research,
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
1alpha-hydroxycholecalciferol and renal function.
September 1978, Lancet (London, England),
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
Plasma 25-hydroxycholecalciferol in chronic renal failure.
December 1973, European journal of clinical investigation,
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
Letter: 25-Hydroxycholecalciferol in chronic renal failure.
August 1975, Lancet (London, England),
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
Serum ionized calcium in renal failure --- a guideline for 1alpha-hydroxycholecalciferol treatment.
May 1977, Calcified tissue research,
L Tougaard, and E Sörensen, and J Bröchner-Mortensen, and M S Christensen, and P Rödbro, and A W Sörensen
1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.
May 1977, Calcified tissue research,
Copied contents to your clipboard!